Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic treatment for pain-related behavioral symptoms in dementia
ACTRN12611000062921Phase 3Completed
- Sponsor
- National Health and Medical Research Council
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in pain, Dementia, agitation and 1 more comparing Paracetamol, Codeine and Placebo (3 arms). Primary endpoints: Agitation/Aggression and Pain scores. Started Nov 2011; status: completed.
02
Drugs
acetaminophencodeine
03
Conditions
painDementiaagitationmajor depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12611000062921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000062921.